Storia in 2 fonti

Kailera says obesity pill succeeds in late-stage trial in China

The drug spurred about 10% weight loss over 10 months, though that finding came alongside high rates of gastrointestinal side effects that “alarmed” one analyst.

Raccontata da

biopharmadive.com

endpoints.news

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo1 mese fa

Kailera says obesity pill succeeds in late-stage trial in China

The drug spurred about 10% weight loss over 10 months, though that finding came alongside high rates of gastrointestinal side effects that “alarmed” one analyst.

originale

endpoints.news1 mese fa

Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trials

Hengrui/Kailera's GLP-1 pill HRS-7535 met obesity & diabetes China trial endpoints but showed high nausea & vomiting, raising concerns vs Lilly & Novo pills.

Leggi questa versione → originale

Timeline cronologica

martedì 7 luglio 2026·biopharmadive.com
Kailera says obesity pill succeeds in late-stage trial in China
The drug spurred about 10% weight loss over 10 months, though that finding came alongside high rates of gastrointestinal side effects that “alarmed” one analyst.
martedì 7 luglio 2026·endpoints.news
Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trials
Hengrui/Kailera's GLP-1 pill HRS-7535 met obesity & diabetes China trial endpoints but showed high nausea & vomiting, raising concerns vs Lilly & Novo pills.